Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qinbaiqingfei nongsuowan
- Development stage
- Unknown
- Lead developer
- Heilongjiang Provincial Academy of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qinbaiqingfei Nongsuowan is a traditional Chinese medicine (TCM) developed by the Heilongjiang Provincial Academy of Traditional Chinese Medicine for the treatment of pneumonia caused by *Mycoplasma pneumoniae*. It was the first TCM specifically approved in China for this indication, receiving NMPA approval in 2004. The formulation is a concentrated pill (Nongsuowan) composed of several herbal ingredients, including *Scutellaria baicalensis* (Huangqin), *Stemona sessilifolia* (Baibu), *Platycodon grandiflorus* (Jiegeng), and *Glycyrrhiza uralensis* (Gancao). Its mechanism of action involves a multi-targeted approach, providing anti-mycoplasmal activity, anti-inflammatory effects, and antitussive properties. It is primarily used in pediatric and adult populations to clear lung heat, resolve phlegm, and alleviate cough associated with respiratory infections.
- Brand names
- Qinbaiqingfei Nongsuowan
- Other names
- Qinbai Qingfei Concentrated PillsQinbai Qingfei PillsQinbai Qingfei
Beyond the preview
Go deeper on qinbaiqingfei nongsuowan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qinbaiqingfei nongsuowan.